MétaCan
Menu
Back to cohort
Record W1989623500 · doi:10.1158/1535-7163.pms-b16

Abstract B16: Cells containing mutations in the cohesin component, STAG2, are sensitive to PARP inhibition

2013· article· en· W1989623500 on OpenAlexaff
Melanie L. Bailey, Nigel J. O’Neil, Derek M. van Pel, Phil Hieter

Bibliographic record

VenueMolecular Cancer Therapeutics · 2013
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicMicrotubule and mitosis dynamics
Canadian institutionsUniversity of British Columbia
Fundersnot available
KeywordsCohesinSynthetic lethalityOlaparibEstablishment of sister chromatid cohesionBiologyCancer cellChromosome instabilityCancer researchMolecular biologyPARP1Genome instabilityGeneticsCancerDNA repairDNA damagePoly ADP ribose polymeraseChromosomeDNAPolymeraseGene

Abstract

fetched live from OpenAlex

Abstract Synthetic lethality (SL) has been proposed as a strategy to specifically target cells harboring cancer mutations while leaving unmutated, non-cancer cells unaffected, thus minimizing drug side effects. One genetic vulnerability common to many types of cancer is chromosome instability (or CIN). CIN can lead to increased genetic mutation and aneuploidy in cancer cells thereby distinguishing them from their normal neighbors and making it a possible candidate phenotype to target by SL. Here, we focus on the multifunctional cohesin complex that is critical for accurate chromosome segregation and genome stability because it tethers sister chromatids together after DNA replication and maintains cohesion until their separation in anaphase. Although several subunits of cohesin have been shown to be mutated in tumors, recent data identifies a cohesin component, STAG2 (Stromal Antigen 2 or SA-2) as a highly mutated gene in several types of cancer including Ewing's sarcoma, melanoma and glioblastomas (GBMs). As a previous study in our lab had shown that knockdown of any one of the core cohesion subunits SMC1A, SMC3 or RAD21 can render cells sensitive to the poly ADP-ribose polymerase (PARP) inhibitor olaparib, we sought to determine if cell lines harboring cancer-specific STAG2 mutations showed similar sensitivity. Using paired GBM cell lines containing either a truncated STAG2 or wild-type STAG2 knock-in, we found that STAG2 mutation status was, indeed, associated with significantly decreased proliferation in the presence of PARP inhibition. Interestingly, olaparib treatment led to an accumulation of cells in the G2 phase of the cell cycle and an increase in DNA damage markers. Furthermore, in the presence of increasing concentrations of olaparib, a higher percentage of STAG2-mutated cells had micronuclei and fragmented nuclei compared to their wild-type STAG2 knock-in counterparts. Taken together, these data suggest that the DNA repair enzyme PARP may be a potential therapeutic SL target for tumors harboring mutations in STAG2. Citation Format: Melanie L. Bailey, Nigel J. O'Neil, Derek M. van Pel, Phil Hieter. Cells containing mutations in the cohesin component, STAG2, are sensitive to PARP inhibition. [abstract]. In: Proceedings of the AACR Precision Medicine Series: Synthetic Lethal Approaches to Cancer Vulnerabilities; May 17-20, 2013; Bellevue, WA. Philadelphia (PA): AACR; Mol Cancer Ther 2013;12(5 Suppl):Abstract nr B16.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.024
Threshold uncertainty score0.668

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.017
GPT teacher head0.266
Teacher spread0.249 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations5
Published2013
Admission routes1
Has abstractyes

Explore more

Same venueMolecular Cancer TherapeuticsSame topicMicrotubule and mitosis dynamicsFrench-language works237,207